Effect of 1 Year of an Intentional Weight Loss Intervention on Bone Mineral Density in Type 2 Diabetes: Results from the Look AHEAD Randomized Trial
Overview
Authors
Affiliations
Intentional weight loss is an important component of treatment for overweight patients with type 2 diabetes, but the effects on bone density are not known. We used data from the Look AHEAD trial to determine the impact of an intensive lifestyle weight loss intervention (ILI) compared with diabetes support and education (DSE) on changes in bone mineral density (BMD) over 12 months. Overweight and obese adults with type 2 diabetes were randomly assigned to ILI or DSE. In a substudy of BMD conducted at 5 of 16 clinical centers, hip, spine, and whole body dual X-ray absorptiometry scans were obtained at baseline and 1-year later on 642 of 739 ILI and 632 of 740 DSE participants. At baseline, mean age was 58.4 years, and average body mass index was 35.2 kg/m(2). Total hip BMD T-score was <-2.5 in 1% and <-1.0 in 8%. At 1 year, weight loss was greater in ILI than DSE (-8.6% versus -0.7%), and glycemic control and fitness were also improved. Bone loss over 1 year was greater in ILI at the total hip (-1.4% versus -0.4%; p < 0.001) and femoral neck (-1.5% versus -0.8%; p = 0.009), but change in BMD for the lumbar spine and whole body did not differ between groups. In ILI, bone loss at the total hip was independently associated with weight loss in men and women and with poorer glycemic control in men, but was not associated with changes in fitness. One year of an intensive lifestyle intervention in adults with type 2 diabetes, resulting in weight loss, was associated with a modest increase in hip bone loss despite improved fitness and glycemic control.
Calorie restriction induces mandible bone loss by regulating mitochondrial function.
Liu L, Le P, DeMambro V, Feng T, Liu H, Ying W Bone. 2024; 190:117326.
PMID: 39528064 PMC: 11618829. DOI: 10.1016/j.bone.2024.117326.
Liu L, Le P, Stohn J, Liu H, Ying W, Baron R J Bone Miner Res. 2024; 39(8):1188-1199.
PMID: 38995944 PMC: 11337945. DOI: 10.1093/jbmr/zjae104.
Jensen S, Sorensen V, Sandsdal R, Lehmann E, Lundgren J, Juhl C JAMA Netw Open. 2024; 7(6):e2416775.
PMID: 38916894 PMC: 11200146. DOI: 10.1001/jamanetworkopen.2024.16775.
Methionine as a regulator of bone remodeling with fasting.
Amorim T, Kumar N, David N, Dion W, Pagadala T, Doshi N JCI Insight. 2024; 9(12).
PMID: 38780544 PMC: 11383369. DOI: 10.1172/jci.insight.177997.
Ashby-Thompson M, Heshka S, Anderson A, Pownall H, Laferrere B, Balasubramanyam A Obesity (Silver Spring). 2024; 32(6):1093-1101.
PMID: 38741246 PMC: 11301635. DOI: 10.1002/oby.24025.